ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Mundipharma and Cidara’s rezafungin gets Orphan Drug Designation in EU pharmaceutical-technology
January 28, 2021The European Commission (EC) has adopted the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) recommendation to grant Orphan Drug Designation (ODD) to Mundipharma and Cidara Therapeutics’ rezafungin for treating ...
Pharma Sources Insight July 2025
